News Focus
News Focus
icon url

DewDiligence

05/18/22 4:09 PM

#242537 RE: DewDiligence #241100

ENTA’s phase-2b trial in RSV misses primary endpoint:

https://ir.enanta.com/news-releases/news-release-details/enanta-pharmaceuticals-reports-topline-data-rsvp-study-edp-938

From the recent price action, it seems that this result may have been leaked.